In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer

scientific article published on September 2009

In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/MP900021Q
P932PMC publication ID2760434
P698PubMed publication ID19507896
P5875ResearchGate publication ID26277577

P2093author name stringYou Han Bae
Dongin Kim
Eun Seong Lee
Zhong Gao Gao
P2860cites workCancer nanotechnology: opportunities and challengesQ29615481
Nanocarriers as an emerging platform for cancer therapyQ29616699
Targeting multidrug resistance in cancerQ29616803
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewQ29617388
Drug delivery systems: entering the mainstreamQ29618136
Membrane fusion induced by vesicular stomatitis virus depends on histidine protonationQ31130651
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriersQ33235069
Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cellsQ33688530
Role of P-glycoprotein in drug dispositionQ33845762
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugsQ34060806
Long-circulating and target-specific nanoparticles: theory to practiceQ34253450
Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptorsQ34319102
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromoleculesQ34408529
The cell biology of multiple drug resistanceQ34661261
Targeted drug delivery by thermally responsive polymers.Q34804805
PEGylated nanoparticles for biological and pharmaceutical applicationsQ35082131
Ligand-targeted liposomal anticancer drugsQ35157616
Cell biological mechanisms of multidrug resistance in tumorsQ35179585
Multidrug resistance reversal agentsQ35570886
Liposome-based approaches to overcome anticancer drug resistanceQ35595419
Nanoparticle and targeted systems for cancer therapyQ35879221
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distributionQ36684624
Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.Q36920351
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsQ37263033
Intracellular pH and the control of multidrug resistanceQ37558951
Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.Q39925586
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticlesQ40104142
Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cellsQ40154265
A bacterial protein enhances the release and efficacy of liposomal cancer drugsQ40204842
Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistryQ40208632
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.Q40277654
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle systemQ40302466
Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrierQ40357454
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.Q40447478
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.Q40470446
Multidrug resistance-associated protein (MRP) gene expression in human lung cancer.Q41188827
P-glycoprotein and multidrug resistanceQ41239416
Modulation and prevention of multidrug resistance by inhibitors of P-glycoproteinQ41578162
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micellesQ43089706
HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemiaQ43901439
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesQ43973334
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myelomaQ44103318
Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilizationQ44525531
Polymeric micelle for tumor pH and folate-mediated targetingQ44558767
Auxin induces exocytosis and the rapid synthesis of a high-turnover pool of plasma-membrane H(+)-ATPaseQ47730735
Prodrug chemotherapeutics bypass p-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivityQ47913323
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pumpQ49062104
The design and synthesis of polymers for eukaryotic membrane disruption.Q52536241
Differential macromolecular leakage from the vasculature of tumorsQ68951976
A novel rodent mammary window of orthotopic breast cancer for intravital microscopyQ73245873
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
micellesQ421110
folic acidQ127060
P304page(s)1353-1362
P577publication date2009-09-01
P1433published inMolecular PharmaceuticsQ3011140
P1476titleIn vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer
P478volume6

Reverse relations

cites work (P2860)
Q36412928Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Q37031597Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review
Q40568410Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading.
Q51025906Brushed block copolymer micelles with pH-sensitive pendant groups for controlled drug delivery.
Q39365167CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells
Q39062600Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy
Q38067265Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Q30421664Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
Q39559271Effect of local dual frequency sonication on drug distribution from polymeric nanomicelles.
Q35560114Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel
Q28073956Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.
Q38955404Enhanced synergism of thermo-chemotherapy by combining highly efficient magnetic hyperthermia with magnetothermally-facilitated drug release.
Q38168377Exploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies.
Q38161447Extracellular stability of nanoparticulate drug carriers
Q28486235Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor
Q39115464Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle.
Q35664403Folate-decorated nanogels for targeted therapy of ovarian cancer.
Q83528769Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier
Q39027223Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles
Q53686098In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Q39296686In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer.
Q39526281Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer
Q38119471Multifunctional nanomicellar systems for delivering anticancer drugs.
Q35809872Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Q37798555Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
Q55018323Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.
Q37822160Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer
Q38938291PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking
Q53181077Photo-controlled metal-ion (Zn2+ and Cd2+) release in aqueous Tween-20 micelle solution.
Q41057564Physicochemical characterization of drug nanocarriers.
Q30478123Polymeric micelles in anticancer therapy: targeting, imaging and triggered release
Q38575282Polymeric nanoparticles: the future of nanomedicine
Q35023993Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles
Q37997512Recent advances in drug delivery strategies for treatment of ovarian cancer
Q37974590Recent advances in stealth coating of nanoparticle drug delivery systems
Q90345858Redox-responsive biocompatible nanocarriers based on novel heparosan polysaccharides for intracellular anticancer drug delivery
Q34459637Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy
Q57341240Stimulation-Sensitive Drug Delivery Systems
Q90169696Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
Q38062891Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery
Q38032480Stimulus-responsive nanopreparations for tumor targeting
Q38062884Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers.
Q38928745Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo.
Q38809044The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer
Q33965271The benefits and challenges associated with the use of drug delivery systems in cancer therapy
Q34615075The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
Q30354655Theranostic Probes for Targeting Tumor Microenvironment: An Overview.
Q50504656Tunable pH-sensitive poly(β-amino ester)s synthesized from primary amines and diacrylates for intracellular drug delivery.
Q37780547Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool
Q34139159Zwitterionic chitosan derivatives for pH-sensitive stealth coating
Q38127747pH- and ion-sensitive polymers for drug delivery
Q38168593pH-sensitive drug-delivery systems for tumor targeting
Q36653608pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery
Q38205583pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances

Search more.